Physician profile
Samirora Lacy
NPI 1598589806
$759.93
in general payments reported to CMS, 2019-2025
11 companies · $746 in 2025
The $746 reported for 2025 was more than what 82% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $14.35 · 2025: $746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $681 · Education: $78.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $680.94 |
| Education | $78.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $159.62 | 2025 | Auvelity |
| Abbvie INC. | $151.72 | 2025 | |
| Astellas Pharma US INC | $114.59 | 2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $103.14 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $63.06 | 2024-2025 | Caplyta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.91 | 2025 | Jardiance |
| Mayne Pharma Commercial LLC | $33.03 | 2025 | |
| Lilly USA, LLC | $24.09 | 2025 | Mounjaro |
| Antares Pharma, INC. | $23.85 | 2025 | Xyosted |
| Evofem Biosciences, INC. | $19.90 | 2025 | Solosec, Phexx, Phexxi |
| Exact Sciences Corporation | $16.02 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samirora Lacy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.